Human gene copy number variation and infectious disease

Hum Genet. 2014 Oct;133(10):1217-33. doi: 10.1007/s00439-014-1457-x. Epub 2014 Jun 5.

Abstract

Variability in the susceptibility to infectious disease and its clinical manifestation can be determined by variation in the environment and by genetic variation in the pathogen and the host. Despite several successes based on candidate gene studies, defining the host variation affecting infectious disease has not been as successful as for other multifactorial diseases. Both single nucleotide variation and copy number variation (CNV) of the host contribute to the host's susceptibility to infectious disease. In this review we focus on CNV, particularly on complex multiallelic CNV that is often not well characterised either directly by hybridisation methods or indirectly by analysis of genotypes and flanking single nucleotide variants. We summarise the well-known examples, such as α-globin deletion and susceptibility to severe malaria, as well as more recent controversies, such as the extensive CNV of the chemokine gene CCL3L1 and HIV infection. We discuss the potential biological mechanisms that could underly any genetic association and reflect on the extensive complexity and functional variation generated by a combination of CNV and sequence variation, as illustrated by the Fc gamma receptor genes FCGR3A, FCGR3B and FCGR2C. We also highlight some understudied areas that might prove fruitful areas for further research.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Chemokines, CC / genetics
  • Communicable Diseases / genetics*
  • DNA Copy Number Variations*
  • Gene Dosage*
  • HIV Infections / genetics
  • HIV-1
  • Host-Pathogen Interactions / genetics
  • Host-Pathogen Interactions / immunology
  • Humans
  • Malaria / genetics
  • Malaria / parasitology
  • Receptors, IgG / genetics

Substances

  • CCL3L1 protein, human
  • Chemokines, CC
  • Receptors, IgG